BioNTech Investor Day Presentation Deck

2 Variant-adapted vaccines Next-generation vaccine approaches aim to provide durable variant protection 17 COMIRNATY IN Omicron-adapted Kil ¿ Mono-/Multi-valent Clinical data presented at VRBPAC meeting June 2022 Variant adapted and next-generation vaccine approaches Rolling submissions initiated in US and EU KM T-cell enhancing K Pan-coronavirus NUA Expected to enter the clinic in 2H 2022 CAR Pandemic prep. Pfizer BIONTECH 66

View entire presentation